LLY Competitors & Alternatives
Compare Eli Lilly and Company with similar stocks in the same industry
Drug Manufacturers - General
LLY
Main Stock$1115.70
Tradestie Score
47
Market Cap
$739.95B
P/E Ratio
37.7
Revenue Growth
0.5%
Analyst Upside
+17.9%
Top Competitors
18 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVGO
Broadcom Inc. Common Stock
|
$361.99
|
$1.57T | 46.1 | 70 | Compare |
|
JNJ
Johnson & Johnson
|
$265.58
|
$448.07B | 31.0 | 46 | Compare |
|
ABBV
ABBVIE INC.
|
$257.12
|
$431.71B | 70.8 | 53 | Compare |
|
NVO
Novo-Nordisk A/S
|
$43.07
|
$262.92B | 10.9 | 38 | Compare |
|
AZN
AstraZeneca PLC
|
$160.17
|
$261.56B | 23.5 | 52 | Compare |
|
NVS
Novartis AG
|
$137.16
|
$254.99B | 20.7 | 42 | Compare |
|
ABT
Abbott Laboratories
|
$101.95
|
$232.30B | 34.0 | 41 | Compare |
|
MRK
Merck & Co., Inc.
|
$143.93
|
$225.13B | 117.7 | 42 | Compare |
|
AMGN
Amgen Inc
|
$377.35
|
$160.70B | 24.3 | 43 | Compare |
|
PFE
Pfizer Inc.
|
$27.72
|
$154.70B | 36.4 | 48 | Compare |
More LLY Analysis
Data updated: Sep 12, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
18 stocks in this industry